|
Franco Momoli
fmomoli@ohri.ca
OHRI Phone (613) 737-8899 x73387
CHEO-RI Phone (613) 737-7600 x4144
 General Campus
(see Contact page for maps)
  |
Associate Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute
Biographical Sketch
Dr. Momoli has a masters from the Department of Psychiatry, McGill University, where he conducted behavioural and neuroscience research on animal models of Alzheimer’s disease. Shifting to the field of occupational and environmental cancer, he earned a doctorate from the Department of Epidemiology and Biostatistics, McGill University, where his work focused on applying methods for large-scale screening analyses to a study of occupational exposures and lung cancer. During his post-doctoral fellowship at the McLaughlin Centre for Population Health Risk Assessment, at the University of Ottawa, Dr. Momoli worked on studies of lung cancer risk in relation to exposure to polycyclic aromatic hydrocarbons, and risk of intracranial tumours in relation to the use of mobile phones. His research interests include statistical methods concerning confounder selection and applications that “smuggle” simplified Bayesian methods into epidemiology.
He joined the OHRI Methods Centre and the CHEO-RI Clinical Reseach Unit as a consulting epidemiologist in 2009.
List of various publications
Momoli F, Abrahamowicz M, Parent M-E, Krewski D, Siemiatycki J (2010) Analysis of multiple exposures: An empirical comparison of results from conventional and semi-Bayes modelling strategies. Epidemiology 21: 144-151.
Yenugadhati, N., Band, P.R., Birkett, N.J., Fang, R., Momoli, F., MacArthur, A.C., Krewski, D. (2009) Industries and Lung Cancer: A Population-Based Case-Control Study in British Columbia. Journal of Toxicology and Environmental Chemistry 91: 451-484.
Yenugadhati, N., Birkett, N.J., Momoli, F., Krewski, D. (2009) Occupations and Lung Cancer: A Population-Based Case-Control Study in British Columbia. Journal of Toxicology and Environmental Health – Part A – Current Issues 72: 658-675.
Krewski D, Turner MC, Boom N, Momoli F (2008) Environmental Health Overview, In: International Encyclopedia of Public Health, Elsevier, pages 361-373.
Momoli F., M.-E. Parent, M. Abrahamowicz, L. Nadon, R. Lakhani, B. Latreille, D. Krewski, J. Siemiatycki (2007) Lung cancer risk from selected occupational chemicals. AJE 165: S102.
Wolfson C, Perrault A, Moride Y, Esdaile JM, Abenhaim L, Momoli F (2002) A Case-Control Analysis of Nonsteroidal Anti-inflammatory Drugs and Alzheimer's Disease: Are They Protective? Neuroepidemiology 21, 81-86.
Kulaga S, Hagel B, Brogly S, Momoli F (2002) Epidemiology Research. The Lancet 360 (9328): 259-260.
Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y (2001) Donepezil and Rivastigmine in the Treatment of Alzheimer’s Disease: A Best Evidence Synthesis of the Evidence for Efficacy and Cost-Effectiveness. Clinical Therapeutics 24 (6), 862-886.
Oremus M, Wolfson C, Perrault A, Demers, L, Momoli F, Moride Y (2001) Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer’s disease drug trials. Dementia and Geriatric Cognitive Disorders 12, 232-236.
Nalbantoglu J, Tirado-Santiago G, Lahsaini A, Poirier J, Goncalves O, Verge G, Momoli F, Welner S, Massicotte G, Julien J-P, Shapiro M (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505.
| |
